Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rennes University Hospital
Our study is a nationwide population-based prospective cohort on 4 years thanks to the French Health Reimbursement Agency database (Système National d'Information Inter-Régimes de l'Assurance Maladie, SNIIRAM) and French hospital discharge database (Programme de Médicalisation des Systèmes d'Information; PMSI). A unique civil registration number has been assigned to all French residents and this number unambiguously links those two databases.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Adults men, age greater 18 years,
Affiliation to French Health System,
Diagnosis of prostate cancer
At least one dispensation (leading to a reimbursement claim) in a 1.5 year period of an androgen-deprivation therapy or a hospitalization for orchiectomy.
You may not be if
Orchiectomy for another reason that prostate cancer.
Patients treated with both Gonadotropin Releasing Hormone agonists and bilateral orchiectomy will be excluded from analyses.
